(PharmaNewsWire.Com, August 04, 2017 ) According to the report North America Injectable Drug Delivery Market, published by Market Data Forecast, the North America market is projected to reach 195.49 billion by 2021, at a CAGR of 11.009%, from 2016 to 2021.
Injectable drug delivery technologies allow the transport of drugs detailed in fluid form and encourage the fast transport of the drug into the body. It likewise helps in managing drugs in comatose and unconscious patients. These delivery frameworks are generally accepted because of their recognition of a faster onset reaction with high adequacy. Also, in the recent years, this market has developed because of the expanded predominance of cancer and diabetes.
North America Injectable Drug Delivery Market: Drivers & Restraints The key factors driving the Injectable Drug Delivery Market are Increased prevalence of chronic diseases, Technological advances in the form of nanotechnologies, Rising demand for biologics in the pharmaceutical industry and Increased patient compliance. The Restraining factors affecting the IDD market include Possibility of injuries and infections via usage, Product recalls, Emergence of alternative drug delivery systems, Regulatory framework concerns.
North America Injectable Drug Delivery Market: Segmentation
By Device Type Introduction Self-injection Devices Conventional Devices Y-o-Y Growth Analysis, By Device Type Market Attractiveness Analysis, By Device Type Market Share Analysis, By Device Type
By Formulation Introduction Conventional Drug Delivery Novel Drug Delivery Y-o-Y Growth Analysis, By Formulation Market Attractiveness Analysis, By Formulation Market Share Analysis, By Formulation
By Therapeutic Use Introduction Autoimmune Disorders Hormonal Disorders Oncology Y-o-Y Growth Analysis, By Therapeutic Use Market Attractiveness Analysis, By Therapeutic Use Market Share Analysis, By Therapeutic Use
By End-user Application Introduction Hospitals Homecare Settings Research Institutes Clinical Laboratories Other Y-o-Y Growth Analysis, By End-user Application Market Attractiveness Analysis, By End-user Application Market Share Analysis, By End-user Application
North America Injectable Drug Delivery Market: Overview In the recent years, the use of injectable drug delivery has increased due to increasing incidences of cancer and diabetes. Technological advancements, improving patient compliance, beneficial reimbursement policies, and rise of biologics in the pharmaceutical market are some of the key factors driving the growth of the global injectable drug delivery market. In addition, increasing healthcare awareness and increasing geriatric population are also fueling the growth of the global injectable drug delivery market.
The North America injectable drug delivery formulations technologies market is the largest segment in the market. This is due to a surge of biologics and the development of nanotechnologies. In the therapeutic field, hormonal disorders command the major segment due to the high demand of injectable in the treatment of diabetes. The growth of the injectable drug delivery technologies market is primarily triggered by favorable reimbursement policies on injectable drugs and devices, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes in North America, and improving patient compliance. The evolving opportunities in this market for manufacturers include development of biosimilars in pharmaceutical markets and focus of pharmaceutical manufacturers towards emerging markets.
North America Injectable Drug Delivery Market: Region-wise Outlook On the basis of geography, the North America market is analyzed under various regions namely U.S and Canada. Injectable Drug Delivery Market was dominated by North America, with the overall market share of over 35% globally. North America was followed by Europe and Asia-Pacific.
Key Questions Answered
What will be the market growth till 2021 and what will be the resultant market forecast in the year? What was the market size from 2016 to 2021 ?
What is the current and future North America Injectable Drug Delivery Market outlook in global? What trends are affecting the North America market?
What is the competitive landscape and market share of major players in the Global Injectable Drug Delivery space in North America?
What are the key, high growth markets that North America Injectable Drug Delivery manufacturers should expand into? Which market segments are growing the fastest?
What are the unmet needs with the Injectable Drug Delivery Market currently on the market? How will emerging technologies fulfil these unmet needs?
What is physician perception and market outlook of Injectable Drug Delivery?
What are the challenges and barriers that have hindered widespread adoption of Injectable Drug Delivery?
A comprehensive mapping of the competitive landscape and the market participants behaviour ?
North America Injectable Drug Delivery Market: Key Players Some of the major companies dominating the market, by their products and services include Alkermes Inc., Bend Research, BIND Biosciences, Inc., Endocyte, Genentech Inc., MicroCHIPS, Inc., Pearl Therapeutics Inc., Polymer Factory, Presage Bioscience, QLT Inc., UCB Group.
Reasons to buy North America Injectable Drug Delivery Market Report:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
